Clinical trial
Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation
NCT00628394
Study timeline
Study start (unknown)2003-09-01Date precision: month
Registry last updated2020-09-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cognition in Schizophreniaunresolved
Interventions
AtomoxetineDRUG · verified · RxNorm: atomoxetine
PlaceboDRUG
Sponsors & collaborators
University of Texas Southwestern Medical Centerlead sponsor
National Institute of Mental Health (NIMH)collaborator
Stanley Medical Research Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00628394 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.